Pharma
Duchenne community mourns patient death, but largely stands behind Elevidys gene therapy
A 16-year-old’s death has ignited a debate around gene therapy and led to a pause of European trials.
Gene Therapy
Relevant stories on gene therapy focused on the business, policy, and technology developments happening behind the headlines.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
